These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 28864169)

  • 81. Multi-target Approaches of Epigallocatechin-3-O-gallate (EGCG) and its Derivatives against Influenza Viruses.
    da Silva-Júnior EF; Silva LR
    Curr Top Med Chem; 2022; 22(18):1485-1500. PubMed ID: 35086449
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Biochemical and computational insights of adenosine deaminase inhibition by Epigallocatechin gallate.
    K G A; C S S; J A; C S
    Comput Biol Chem; 2019 Dec; 83():107111. PubMed ID: 31445420
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Tea Polysaccharides as Potential Therapeutic Options for Metabolic Diseases.
    Chen G; Chen R; Chen D; Ye H; Hu B; Zeng X; Liu Z
    J Agric Food Chem; 2019 May; 67(19):5350-5360. PubMed ID: 30474370
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Catechin in Human Health and Disease.
    Isemura M
    Molecules; 2019 Feb; 24(3):. PubMed ID: 30717121
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Can green tea do that? A literature review of the clinical evidence.
    Clement Y
    Prev Med; 2009; 49(2-3):83-7. PubMed ID: 19465043
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeting of histamine producing cells by EGCG: a green dart against inflammation?
    Melgarejo E; Medina MA; Sánchez-Jiménez F; Urdiales JL
    J Physiol Biochem; 2010 Sep; 66(3):265-70. PubMed ID: 20652470
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Epigallocatechin-3-gallate exhibits anti-inflammatory effects in a human interface dermatitis model-implications for therapy.
    Braegelmann C; Niebel D; Ferring-Schmitt S; Fetter T; Landsberg J; Hölzel M; Effern M; Glodde N; Steinbuch S; Bieber T; Wenzel J
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):144-153. PubMed ID: 34585800
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cardioprotective effect of epigallocatechin-3-gallate against myocardial infarction in hypercholesterolemic rats.
    Zhong W; Huan XD; Cao Q; Yang J
    Exp Ther Med; 2015 Feb; 9(2):405-410. PubMed ID: 25574206
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Pharmacological Actions and Underlying Mechanisms of Catechin: A Review.
    Baranwal A; Aggarwal P; Rai A; Kumar N
    Mini Rev Med Chem; 2022; 22(5):821-833. PubMed ID: 34477517
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Advances in the Anti-Atherosclerotic Mechanisms of Epigallocatechin Gallate.
    Liu Y; Long Y; Fang J; Liu G
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999821
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Bioactive compounds in green tea may improve transplant tolerance: A computational systems biology analysis.
    Ayyadurai VAS; Deonikar P
    Clin Nutr ESPEN; 2021 Dec; 46():439-452. PubMed ID: 34857232
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Antioxidant and Antimicrobial Activities of (-)-Epigallocatechin-3-gallate (EGCG) and its Potential to Preserve the Quality and Safety of Foods.
    Nikoo M; Regenstein JM; Ahmadi Gavlighi H
    Compr Rev Food Sci Food Saf; 2018 May; 17(3):732-753. PubMed ID: 33350134
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Molecular Mechanisms of Epigallocatechin-3-Gallate for Prevention of Chronic Kidney Disease and Renal Fibrosis: Preclinical Evidence.
    Kanlaya R; Thongboonkerd V
    Curr Dev Nutr; 2019 Sep; 3(9):nzz101. PubMed ID: 31555758
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Mechanism of (-)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma.
    Park S; Jeong GH; Jee SH; Kim TH; Kim SB
    Sci Rep; 2022 Sep; 12(1):15396. PubMed ID: 36100688
    [TBL] [Abstract][Full Text] [Related]  

  • 95. A Simple, Label-Free, and High-Throughput Method to Evaluate the Epigallocatechin-3-Gallate Impact in Plasma Molecular Profile.
    Araújo R; Ramalhete L; Da Paz H; Ribeiro E; Calado CRC
    High Throughput; 2020 Apr; 9(2):. PubMed ID: 32283584
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Clinical Application of Melatonin in the Treatment of Cardiovascular Diseases: Current Evidence and New Insights into the Cardioprotective and Cardiotherapeutic Properties.
    Pourhanifeh MH; Dehdashtian E; Hosseinzadeh A; Sezavar SH; Mehrzadi S
    Cardiovasc Drugs Ther; 2022 Feb; 36(1):131-155. PubMed ID: 32926271
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications.
    Hua Y; Nair S
    Biochim Biophys Acta; 2015 Feb; 1852(2):195-208. PubMed ID: 24815358
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Management of inflammation in cardiovascular diseases.
    Goswami SK; Ranjan P; Dutta RK; Verma SK
    Pharmacol Res; 2021 Nov; 173():105912. PubMed ID: 34562603
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Label-free biomolecular and cellular methods in small molecule epigallocatechin-gallate research.
    Péter B; Szekacs I; Horvath R
    Heliyon; 2024 Feb; 10(3):e25603. PubMed ID: 38371993
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Bridging the gap: Integrating exercise mimicry into chronic disease management through suppressing chronic inflammation.
    Nasb M; Li F; Dayoub L; Wu T; Wei M; Chen N
    J Adv Res; 2024 May; ():. PubMed ID: 38704088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.